Target intelligence / Profile preview

Serine-rich and transmembrane domain-containing protein 1 (SERTM1)

Target
SERTM1
Molecular classification
Other (unclassified protein; predicted as a transmembrane protein)
01

Overview

Serine-rich and transmembrane domain-containing protein 1 (SERTM1, encoded by the SERTM1 gene, also known as C13orf36) is a putative membrane protein in humans, predicted to be rich in serine residues and to possess transmembrane regions[3][8][9]. Human SERTM1 is classified as a protein-coding gene (Gene ID: 400120, Chromosome 13)[3][8]. Its protein product’s function is not experimentally validated, but it is predicted to localize to cellular membranes[3][9]. SERTM1 is expressed in multiple human tissues, including the brain, but no tissue-specific functional role or linkage to specific physiological or pathophysiological processes has been established[5][6]. There are no reports of SERTM1 as a drug target, disease biomarker, or involvement in signaling pathways, enzyme functions, transport activity, or receptor-like activity based on current genomic and proteomic database annotations[3][8][9]. The gene is sometimes listed as C13orf36 in older literature, reflecting its chromosomal location before formal naming[3]. SERTM1 has been used in transcriptomic profiling as a molecular marker in certain neuronal subtypes (e.g., mitral cell subtypes of the mouse olfactory bulb), but no direct functional role has been assigned[2]. No mechanisms of action, interacting drugs, disease roles, or safety profile are available for this protein at this time.

Other names
SERTM1C13orf36Serine-rich and transmembrane domain-containing protein 1

Beyond the preview

Go deeper on Serine-rich and transmembrane domain-containing protein 1 (SERTM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine-rich and transmembrane domain-containing protein 1 (SERTM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call